Lateral Mini Approach vs Anterior Approach for Plating of Proximal Humerus Fracture (HURA)

April 29, 2021 updated by: Dominique Rouleau, Université de Montréal

A Randomized Clinical Trail Comparing a Lateral Minimally Invasive Approach and the Traditional Anterior Approach for Plating of Proximal Humerus Fractures

A prospective randomized clinical trial is proposed to compare the plate fixation of proximal humerus fractures using a minimally invasive lateral approach and the traditional anterior approach.Forty five patients will be assigned to each approach (total of 90 patients) and will be assessed 7 times over a two-year period. The trial's primary objectives will be to demonstrate the efficacy of the plating technique in terms of speed of recuperation of function. The Quick DASH will be used for evaluation of function.The study will also examine secondary end-points of pain, range of motion, esthetic satisfaction and radiographic outcome, as assessed by the components of the Constant Score3,4, SF-12V2 Questionnaire, and Patient Scare Assessment Scale Questionnaire. Furthermore, the assessment of safety will be based on the rates of all reported complications and adverse events at 2 years

Study Overview

Study Type

Interventional

Enrollment (Actual)

79

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H4J1C5
        • Hopital Sacre-Coeur

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Humeral surgical neck fracture, Neer II valgus-type Neer III
  2. Patient willing to participate in the study
  3. Patient available for follow-up through at least two years
  4. Patient with acceptable preoperative medical clearance and free of, or treated for, medical conditions that would pose excessive operative risk
  5. Patient fluent in French and/or English and able to understand his/her role in the study

Exclusion Criteria:

  1. Inflammatory arthritis
  2. Prior shoulder pathology
  3. Active local or systemic infection
  4. Neurologic or musculoskeletal disease that may adversely affect mobility
  5. Participation in any other pharmaceutical, biologic or medical-device clinical investigation
  6. Severe documented psychiatric disease
  7. Severe ipsilateral elbow or wrist disease
  8. Fracture resistant to reduction attempts through the minimally invasive lateral approach

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lateral, Minimally Invasive Approach
Lateral, Minimally Invasive Approach in GT fractures treated operatively (plates and screws)
A longitudinally oriented, 4-cm incision will be made laterally starting at the acromion. The deltoid will be split proximally at the most strategic location (vis-à-vis the fracture), and after the deltoid is bluntly elevated from the humerus more distally the axillary nerve will be identified by digital palpation. The nerve is easily identified posteriorly as it emerges from the quadrilateral space. With a finger maintained on the nerve for protection, the plate will be inserted onto the lateral side of the proximal humerus and fixed according to the described technique. A second, 2-cm longitudinal incision will then be made further distally for diaphyseal screw placement. This incision is well distal to the course of the axillary nerve.
Active Comparator: Deltopectoral approach:
Deltopectoral approach for GT fracture treated operatively
Anterior, Delto-Pectoral Approach - A 10-cm incision will be made over the deltopectoral groove, starting at the coracoid process proximally. As the clavipectoral fascia is incised, the cephalic vein will be identified and retracted laterally with the deltoid muscle. The pectoralis major as well as the conjoint tendon will be retracted medially, and the long head of the biceps tendon will be identified and used as a guide for achieving an anatomic reduction of the different fracture parts. Next, internally rotating the humerus will allow access to the lateral side of the proximal humerus, on which the plate will then be fixed according to the described technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Quick DASH
Time Frame: 3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.
3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.

Secondary Outcome Measures

Outcome Measure
Time Frame
SF-12V2 Questionnaire Constant Shoulder Score The Patient Scar Assessment Scale Complication rate
Time Frame: 3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.
3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dominique M Rouleau, MD, Hopital Sacre-Coeur

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2007

Primary Completion (Actual)

July 1, 2019

Study Completion (Actual)

November 1, 2020

Study Registration Dates

First Submitted

January 29, 2008

First Submitted That Met QC Criteria

February 8, 2008

First Posted (Estimate)

February 11, 2008

Study Record Updates

Last Update Posted (Actual)

April 30, 2021

Last Update Submitted That Met QC Criteria

April 29, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HURA1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Closed Fracture Proximal Humerus, Neck

Clinical Trials on Lateral minimally invasive approach (plate fixation)

3
Subscribe